RESUMO
PURPOSE: The aim of this study was to evaluate oncologists' opinions about the use of ionizing radiation in medical imaging of oncology patients. METHODS: An electronic survey was e-mailed to 2,725 oncologists at the top 50 National Cancer Institute-funded cancer centers. The survey focused on opinions on CT dose reduction in oncology patients and current philosophies behind long-term imaging in these patients. RESULTS: The response rate was 15% (415 of 2,725). Eighty-two percent of respondents stated that their patients or families have expressed anxiety regarding radiation dose from medical imaging. Although fewer than half of oncologists (48%) did not know whether CT dose reduction techniques were used at their institutions, only 25% were concerned that small lesions may be missed with low-dose CT techniques. The majority of oncologists (63%) follow National Comprehensive Cancer Network guidelines for imaging follow-up, while the remainder follow other national guidelines such as those of the Children's Oncology Group, the American Society of Clinical Oncology, or clinical trials. Ninety percent of respondents believe that long-term surveillance in oncology patients is warranted, particularly in patients with breast cancer, melanoma, sarcoma, and pediatric malignancies. The majority of oncologists would consider the use of low-dose CT imaging in specific patient populations: (1) children and young women, (2) those with malignancies that do not routinely metastasize to the liver, and (3) patients undergoing surveillance imaging. CONCLUSIONS: Cumulative radiation exposure is a concern for patients and oncologists. Among oncologists, there is support for long-term imaging surveillance despite lack of national guidelines.
Assuntos
Padrões de Prática Médica/estatística & dados numéricos , Doses de Radiação , Radioterapia (Especialidade) , Proteção Radiológica/métodos , Tomografia Computadorizada por Raios X , Fatores Etários , Humanos , Imageamento por Ressonância Magnética , Radioterapia (Especialidade)/normas , Proteção Radiológica/normas , Fatores Sexuais , Inquéritos e Questionários , Tomografia Computadorizada por Raios X/normas , Estados UnidosRESUMO
PURPOSE: Patients with recurrent nephrolithiasis are often evaluated and followed with computerized tomography. Obesity is a risk factor for nephrolithiasis. We evaluated the radiation dose of computerized tomography in obese and nonobese adults. MATERIALS AND METHODS: We scanned a validated, anthropomorphic male phantom according to our institutional renal stone evaluation protocol. The obese model consisted of the phantom wrapped in 2 Custom Fat Layers (CIRS, Norfolk, Virginia), which have been verified to have the same radiographic tissue density as fat. High sensitivity metal oxide semiconductor field effect transistor dosimeters were placed at 20 organ locations in the phantoms to measure organ specific radiation doses. The nonobese and obese models have an approximate body mass index of 24 and 30 kg/m(2), respectively. Three runs of renal stone protocol computerized tomography were performed on each phantom under automatic tube current modulation. Organ specific absorbed doses were measured and effective doses were calculated. RESULTS: The bone marrow of each model received the highest dose and the skin received the second highest dose. The mean ± SD effective dose for the nonobese and obese models was 3.04 ± 0.34 and 10.22 ± 0.50 mSv, respectively (p <0.0001). CONCLUSIONS: The effective dose of stone protocol computerized tomography in obese patients is more than threefold higher than the dose in nonobese patients using automatic tube current modulation. The implication of this finding extends beyond the urological stone population and adds to our understanding of radiation exposure from medical imaging.
Assuntos
Obesidade/complicações , Imagens de Fantasmas , Doses de Radiação , Tomografia Computadorizada por Raios X/efeitos adversos , Carga Corporal (Radioterapia) , Índice de Massa Corporal , Humanos , Masculino , Modelos Teóricos , Nefrolitíase/diagnóstico por imagem , Monitoramento de Radiação/métodos , Recidiva , Valores de Referência , Tomografia Computadorizada por Raios X/métodosRESUMO
OBJECTIVE: The purpose of our study was to investigate whether virtual unenhanced adrenal nodule attenuation values can replace true noncontrast attenuation values. MATERIALS AND METHODS: Twenty-three incidentally discovered adrenal nodules (19 adenomas and four metastases) were identified in 19 patients (11 men and eight women; mean age, 65 years; age range, 38-84 years) who underwent unenhanced single-energy CT followed by contrast-enhanced dual-energy CT on the same scanner. A virtual unenhanced imaging dataset was generated from each dual-energy CT dataset. CT attenuation of each adrenal nodule was measured at the same location on virtual unenhanced images and true unenhanced images by three radiologists and mean values compared using the Student t test. Correlation between virtual unenhanced and true unenhanced values was determined using linear regression analysis. The mean difference and percentage of diagnostic agreement were also determined. Interreader variability was assessed using the intraclass correlation coefficient (ICC). RESULTS: The mean ± SD attenuation values for virtual unenhanced images and true unenhanced images were 14.7 ± 15.1 HU and 12.9 ± 13.4 HU, respectively (p = 0.2). Strong positive correlation was observed between virtual unenhanced images and true unenhanced images (R = 0.83-0.87). The mean difference between virtual unenhanced images and true unenhanced images was 1.8 ± 1.7 HU. Diagnostic agreement between virtual unenhanced images and true unenhanced images was 83-91% for three radiologists. No malignant nodules were misclassified as benign on virtual unenhanced images. The ICC was 0.88 and 0.96 for virtual unenhanced images and true unenhanced images, respectively, indicating high interreader agreement. CONCLUSION: Virtual unenhanced and true unenhanced attenuation measurements of adrenal nodules were not significantly different and showed strongly positive linear correlation. This finding resulted in substantial diagnostic agreement between virtual unenhanced images and true unenhanced images for distinguishing benign from malignant nodules.
Assuntos
Doenças das Glândulas Suprarrenais/diagnóstico por imagem , Imagem Radiográfica a Partir de Emissão de Duplo Fóton/métodos , Tomografia Computadorizada por Raios X/métodos , Neoplasias das Glândulas Suprarrenais/diagnóstico por imagem , Adulto , Idoso , Idoso de 80 Anos ou mais , Meios de Contraste , Feminino , Humanos , Achados Incidentais , Iopamidol , Modelos Lineares , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Técnica de SubtraçãoRESUMO
OBJECTIVE: The objective of our study was to retrospectively determine whether minimal fat renal angiomyolipoma can be differentiated from clear cell or papillary renal cell carcinoma (RCC) in small renal masses using attenuation measurement histogram analysis on unenhanced CT. MATERIALS AND METHODS: Twenty minimal fat renal angiomyolipomas were compared with 22 clear cell RCCs and 23 papillary RCCs using an institutional database. All masses were histologically confirmed and all minimal fat renal angiomyolipomas lacked radiographic evidence of macroscopic fat. Using attenuation measurement histogram analysis, two blinded radiologists determined the percentage of negative pixels within each renal mass. The percentages of negative pixels below attenuation thresholds of 0, -5, -10, -15, -20, -25, and -30 HU were recorded. Sensitivity, specificity, positive predictive value, negative predictive value, and receiver operator characteristic curves for the diagnosis of minimal fat renal angiomyolipoma were generated for each threshold. The Student t test was used to compare radiologists and cohorts. Previously published attenuation and pixel-counting thresholds reported as having a specificity of near 100% for discriminating between minimal fat renal angiomyolipomas and RCCs were analyzed. RESULTS: The mean maximal transverse lesion diameter was 1.8 cm for minimal fat renal angiomyolipomas (SD, 0.5 cm; range, 1.1-3.0 cm), 2.1 cm for clear cell RCCs (SD, 0.5 cm; range, 1.0-2.9 cm), and 2.1 cm for papillary RCCs (SD, 0.7 cm; range, 1.3-3.9 cm). No significant difference in the percentage of negative pixels was found between minimal fat renal angiomyolipomas and clear cell RCCs or between minimal fat renal angiomyolipomas and papillary RCCs at any of the selected attenuation thresholds for either radiologist (p = 0.210-0.499). Radiologist 1 and radiologist 2 used significantly different region-of-interest sizes (p < 0.001), but neither radiologist could differentiate minimal fat renal angiomyolipoma from RCC. No previously published threshold allowed discrimination between minimal fat renal angiomyolipoma and RCC with 100% specificity. CONCLUSION: Attenuation measurement histogram analysis cannot reliably differentiate minimal fat renal angiomyolipoma from RCC.
Assuntos
Angiomiolipoma/diagnóstico por imagem , Carcinoma de Células Renais/diagnóstico por imagem , Neoplasias Renais/diagnóstico por imagem , Tomografia Computadorizada por Raios X , Adulto , Idoso , Angiomiolipoma/patologia , Carcinoma de Células Renais/patologia , Diagnóstico Diferencial , Feminino , Humanos , Neoplasias Renais/patologia , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Interpretação de Imagem Radiográfica Assistida por Computador , Estudos Retrospectivos , Sensibilidade e EspecificidadeRESUMO
OBJECTIVES: To investigate the ability of staging computed tomography (CT) without bowel preparation to accurately localize colonic tumors compared to optical colonoscopy. METHODS: The local institutional review board approved this retrospective and HIPAA-compliant study. Forty-six patients with colonic adenocarcinoma, preoperative colonoscopy, and staging CT within 60 days of resection were included. Patients underwent contrast enhanced CT imaging without bowel preparation or oral contrast. The colon was divided into four segments with the operative reports used as the standard. Rectal and cecal cancers were excluded. CT scans were reviewed by 5 readers in a segmental binary fashion using a 5-point confidence scale in two sessions blinded and unblinded to the colonoscopy report. RESULTS: At surgery 49 tumors were found in 46 patients. Readers detected 86.1%, 74.3%, and 66.9% of lesions with 92.0%, 94.1%, and 95.4% accuracy for confidence scores of ≥ 3, ≥ 4, and 5. CT interobserver agreement was good (κ=0.82) for the unblinded and moderate (κ=0.60) for the blinded read. Colonoscopic localization was only 78.7% accurate with 2 tumors undiscovered. Colonoscopic accuracy was low in the descending colon (57.1%) and the transverse colon (55.6%). CONCLUSIONS: Preoperative staging CT is more accurate than colonoscopy in the localization of colonic tumors.
Assuntos
Colo/diagnóstico por imagem , Neoplasias do Colo/diagnóstico por imagem , Colonografia Tomográfica Computadorizada/métodos , Colonoscopia/métodos , Intensificação de Imagem Radiográfica/métodos , Adulto , Idoso , Idoso de 80 Anos ou mais , Meios de Contraste , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Variações Dependentes do Observador , Imagem Óptica/métodos , Reprodutibilidade dos Testes , Sensibilidade e EspecificidadeRESUMO
PURPOSE: To retrospectively determine whether extrinsic warming of the low-osmolality contrast material iopamidol to 37°C prior to intravenous administration at computed tomography (CT) affects extravasation and allergic-like reaction rates. MATERIALS AND METHODS: The need to obtain informed patient consent was waived for this HIPAA-compliant and institutional review board-approved analysis. All adverse events related to the intravenous administration of iopamidol during CT examinations occurring 200 days before (period 1) and 200 days after (period 2) the cessation of extrinsic contrast material warming (37°C) for intravenous injections of less than 6 mL/sec at Duke University Medical Center (Durham, NC) were retrospectively reviewed. Adverse event rates were compared by using χ2 statistics. RESULTS: There were 12,682 injections during period 1 (10,831 injections of iopamidol 300 and 1851 injections of iopamidol 370) and 12,138 injections (10, 064 injections of iopamidol 300 and 2074 injections of iopamidol 370) during period 2. Adverse event rates for iopamidol 300 were not affected by extrinsic warming (extravasation rates: 0.30% [32 of 10,831] in period 1 vs 0.23% [23 of 10,064] in period 2, P=.64; allergic-like reaction rates: 0.39% [42 of 10,831] in period 1 vs 0.46% [46 of 10,064] in period 2, P=.74; overall adverse events: 0.68% [74 of 10,831] in period 1 vs 0.69% [69 of 10,064] in period 2, P=.99). Discontinuation of extrinsic warming was associated with significantly increased extravasation and overall adverse event rates for iopamidol 370 (extravasation rates: 0.27% [five of 1851] vs 0.87% [18 of 2074], P=.05; allergic-like reaction rates: 0.16% [three of 1851] vs 0.39% [eight of 2074], P=.42; overall adverse events: 0.43% [eight of 1851] vs 1.25% [26 of 2074], P=.02). CONCLUSION: Extrinsic warming (to 37°C) does not appear to affect adverse event rates for intravenous injections of iopamidol 300 of less than 6 mL/sec but is associated with a significant reduction in extravasation and overall adverse event rates for the more viscous iopamidol 370.
Assuntos
Hipersensibilidade a Drogas/epidemiologia , Hipersensibilidade a Drogas/prevenção & controle , Extravasamento de Materiais Terapêuticos e Diagnósticos/epidemiologia , Extravasamento de Materiais Terapêuticos e Diagnósticos/prevenção & controle , Iodo , Tomografia Computadorizada por Raios X/estatística & dados numéricos , Adolescente , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Meios de Contraste , Feminino , Temperatura Alta , Humanos , Lactente , Masculino , Michigan/epidemiologia , Pessoa de Meia-Idade , Prevalência , Medição de Risco , Fatores de Risco , Gestão de Riscos , Adulto JovemRESUMO
PURPOSE: To retrospectively determine the optimal Hounsfield unit threshold and region of interest (ROI) size required to accurately diagnose renal angiomyolipoma (AML) and differentiate it from renal cell carcinoma (RCC). MATERIALS AND METHODS: This retrospective study was institutional review board approved and HIPAA compliant, and the requirement for written informed patient consent was waived. The radiologic reports on 4502 dual-phase abdominal computed tomography (CT) examinations (nonenhanced and nephrographic phases, 5-mm collimation, 120-140 kVp, variable milliampere-second settings) performed in 2872 patients from June 2002 through October 2007 were reviewed. Solid-component masses reported as suspicious for RCC or AML were correlated with histologic and/or follow-up imaging findings. ROIs of three different sizes-tiny (8-13 mm(2)), small (19-24 mm(2)), and medium (30-35 mm(2))-were drawn in the lowest-attenuation focus on images obtained during both phases. The test characteristics (sensitivity, specificity, positive predictive value, negative predictive value, false-positive rate, false-negative rate) of multiple attenuation thresholds at each combination of ROI size and contrast enhancement phase were calculated, and receiver operating characteristic (ROC) curves were derived. Areas under the ROC curve were calculated. RESULTS: There were 217 RCCs and 65 AMLs. With an attenuation threshold of -10 HU or lower at nonenhanced CT, RCC would be misdiagnosed as AML in 11 (5.1%) cases, one (0.5%) case, and one (0.5%) case with use of the tiny, small, and medium ROIs, respectively. With use of the tiny, small, and medium ROIs, misdiagnosis rates would be 2.3%, 0.5%, and 0.5%, respectively, at a threshold of -15 HU or lower and 1.8%, 0%, and 0%, respectively, at a threshold of -20 HU or lower. Areas under the ROC curve for the nonenhanced phase images (range, 0.874-0.889) were superior to those for the nephrographic phase images (range, 0.790-0.826). CONCLUSION: Nonenhanced CT images were superior to nephrographic phase CT images for the diagnosis of AML. An attenuation threshold of -10 HU or lower with an ROI of at least 19-24 mm(2) is optimal for the diagnosis of AML. This threshold is not accurate with use of smaller (8-13-mm(2)) ROIs.
Assuntos
Algoritmos , Angiomiolipoma/diagnóstico por imagem , Neoplasias Renais/diagnóstico por imagem , Intensificação de Imagem Radiográfica/métodos , Tomografia Computadorizada por Raios X/métodos , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma de Células Renais/diagnóstico por imagem , Diagnóstico Diferencial , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Reprodutibilidade dos Testes , Sensibilidade e EspecificidadeRESUMO
OBJECTIVE: The purpose of this study was to assess whether habitus and organ enhancement influence iodine subtraction and should be incorporated into spectral subtraction algorithms. SUBJECTS AND METHODS: This study included 171 patients. In the unenhanced phase, MDCT was performed with single-energy acquisition (120 kVp, 250 mAs) and in the parenchymal phase with dual-energy acquisitions (80 kVp, 499 mAs; 140 kVp, 126 mAs). Habitus was determined by measuring trunk diameters and calculating circumference. Iodine subtraction was performed with input parameters individualized to muscle, fat, and blood ratio. Attenuation of the liver, pancreas, spleen, kidneys, and aorta was assessed in truly and virtually unenhanced image series. Pearson analysis was performed to correlate habitus with the input parameters. Analysis of truly unenhanced and virtually unenhanced images was performed with the Student t test; magnitude of variation was evaluated with Bland-Altman plots. Correction strategies were derived from organ-specific regression analysis of scatterplots of truly unenhanced and virtually unenhanced attenuation and implemented in a pixel-by-pixel approach. Analysis of individual organ correction and truly unenhanced attenuation was performed with the Student t test. RESULTS: The correlations between habitus and blood ratio (r = 0.694) and attenuation variation of fat at 80 kVp (r = -0.468) and 140 kV (r = -0.454) were confirmed. Although overall mean attenuation differed by no more than 10 HU between truly and virtually unenhanced scans overall, these differences varied by organ and were large in individual patients. Paired comparisons of truly and virtually unenhanced measurements differed significantly for liver, spleen, pancreas, kidneys, and aortic blood pool (p < 0.001 for all comparisons), but paired comparisons of truly unenhanced and individually organ-corrected measurements did not differ when organ- and habitus-based correction strategies were applied (p > 0.38 for all comparisons). CONCLUSION: Habitus and organ enhancement influence virtually unenhanced imaging and should be incorporated into spectral subtraction algorithms.
Assuntos
Tamanho Corporal , Meios de Contraste , Hematúria/diagnóstico por imagem , Iopamidol , Imagem Radiográfica a Partir de Emissão de Duplo Fóton , Adulto , Idoso , Idoso de 80 Anos ou mais , Algoritmos , Feminino , Humanos , Rim/diagnóstico por imagem , Fígado/diagnóstico por imagem , Masculino , Pessoa de Meia-Idade , Pâncreas/diagnóstico por imagem , Estudos Prospectivos , Reprodutibilidade dos Testes , Baço/diagnóstico por imagemRESUMO
PURPOSE: To determine whether dual-energy multidetector CT enables detection of renal lesion enhancement by using calculated nonenhanced images with spectral-based extraction in a non-body weight-restricted patient population. MATERIALS AND METHODS: Between January 2008 and December 2009, 139 patients were enrolled in this prospective HIPAA-compliant, institutional review board-approved study. Written informed consent was obtained from all patients. After single-energy nonenhanced 120-kVp CT images were acquired, contrast material-enhanced dual-energy multidetector CT images were acquired at 80 and 140 kVp. Calculated nonenhanced images were generated by using spectral-based iodine extraction. Lesion attenuation was measured on the acquired nonenhanced, calculated nonenhanced, and 140-kVp contrast-enhanced nephrographic images. Enhancement, defined as a 15-HU or greater increase in attenuation on the nephrographic images, was assessed by using the baseline attenuation on the acquired and calculated nonenhanced images. Acquired nonenhanced versus calculated nonenhanced image attenuation, as well as enhancement values, were compared by using paired Student t tests and Bland-Altman plots. RESULTS: Hypoattenuating (n = 66) and hyperattenuating (n = 28) cysts, angiomyolipomas (n = 18), and solid enhancing lesions (n = 27) were detected. Mean attenuation values for hypoattenuating cysts on the acquired and calculated nonenhanced CT images were 6.5 HU ± 5.8 (standard deviation) and 8.1 HU ± 3.1 (P = .13), respectively, with corresponding enhancement values of 1.1 HU ± 5.2 and -0.5 HU ± 6.2 (P = .12), respectively. Mean values for hyperattenuating cysts were 29.4 HU ± 5.6 on acquired images and 31.7 HU ± 5.1 on calculated images (P = .39) (corresponding enhancement, 4.7 HU ± 3.3 and 2.3 HU ± 4.1, respectively; P = .09). Mean values for fat-containing enhancing lesions were -90.6 HU ± 24.7 on acquired images and -85.9 HU ± 23.7 on calculated images (P = .57) (corresponding enhancement, 18.2 HU ± 10.1 and 13.6 HU ± 10.7, respectively; P = .19). Mean attenuation values for solid enhancing lesions were 26.0 HU ± 15.0 on acquired images and 27.7 HU ± 14.9 on calculated images (P = .45) (corresponding enhancement, 60.3 HU ± 13.1 and 58.3 HU ± 15.5, respectively; P = .38). CONCLUSION: Dual-energy CT acquisitions with spectral-based postprocessing enabled accurate detection of renal lesion enhancement across the attenuation spectrum of frequently encountered renal lesions in a non-body habitus-restricted patient population.
Assuntos
Iopamidol , Doenças Renais Císticas/diagnóstico por imagem , Neoplasias Renais/diagnóstico por imagem , Imagem Radiográfica a Partir de Emissão de Duplo Fóton/métodos , Tomografia Computadorizada por Raios X/métodos , Adulto , Idoso , Diagnóstico Diferencial , Feminino , Humanos , Pessoa de Meia-Idade , Reprodutibilidade dos Testes , Sensibilidade e EspecificidadeRESUMO
PURPOSE: To retrospectively test the null hypotheses that the qualitative appearance of DWI and the signal intensity values in DWI and corresponding ADC values of the liver, spleen, pancreas and kidneys are identical before and after the administration of gadolinium. MATERIALS AND METHODS: Following IRB approval, DWI was acquired in 50 patients (25 male; mean age 54.9 years) prior to and after contrast administration, using single-shot echo planar imaging with b-values of 50 s/mm2 and 800 s/mm2 at 3 T. Binomial analysis was used to determine which image set was more significantly preferred in conveying the diffusion information. Pre- and post-gadolinium DWI and ADC values of corresponding regions of each organ were analyzed using standardized signal intensity measurements. RESULTS: Pre-contrast DWI images of the liver, spleen, and pancreas were preferred 52%, 49%, and 58%, respectively, with none of the differences being statistically significant. DWI of the kidneys was preferred on pre-contrast images in 83% (p<0.001). In the liver and spleen, contrast caused a significant increase in the post-contrast DWI signal intensity values at b=50 (p<0.02) and b=800 (p<0.05) but had no statistically significant effect on the ADC value (p>0.40). Pancreatic DWI signal intensity and ADC values pre- and post-contrast were also not significantly different (p=0.489). In the renal parenchyma, significant decrease in the values of DWI at b=50 (p<0.01) and b=800 (p<0.01) as well as ADC (p<0.02) was demonstrated following gadolinium administration. CONCLUSION: Intravenous gadolinium administration does not make a statistically significant difference in the qualitative appearance or ADC measurements of the liver, spleen, or pancreas when comparing pre-contrast to post-contrast DWI. In the kidneys, however, ADC values are significantly lower post-contrast with the pre-contrast diffusion weighted images also being qualitatively preferred.
Assuntos
Meios de Contraste , Imagem de Difusão por Ressonância Magnética/métodos , Gadolínio DTPA , Nefropatias/diagnóstico , Hepatopatias/diagnóstico , Meglumina/análogos & derivados , Compostos Organometálicos , Pancreatopatias/diagnóstico , Esplenopatias/diagnóstico , Adulto , Análise de Variância , Meios de Contraste/administração & dosagem , Imagem Ecoplanar , Feminino , Gadolínio DTPA/administração & dosagem , Humanos , Masculino , Meglumina/administração & dosagem , Pessoa de Meia-Idade , Compostos Organometálicos/administração & dosagem , Estudos RetrospectivosRESUMO
Dual-energy CT provides information about how substances behave at different energies, the ability to generate virtual unenhanced datasets, and improved detection of iodine-containing substances on low-energy images. Knowing how a substance behaves at two different energies can provide information about tissue composition beyond that obtainable with single-energy techniques. The term K edge refers to the spike in attenuation that occurs at energy levels just greater than that of the K-shell binding because of the increased photoelectric absorption at these energy levels. K-edge values vary for each element, and they increase as the atomic number increases. The energy dependence of the photoelectric effect and the variability of K edges form the basis of dual-energy techniques, which may be used to detect substances such as iodine, calcium, and uric acid crystals. The closer the energy level used in imaging is to the K edge of a substance such as iodine, the more the substance attenuates. In the abdomen and pelvis, dual-energy CT may be used in the liver to increase conspicuity of hypervascular lesions; in the kidneys, to distinguish hyperattenuating cysts from enhancing renal masses and to characterize renal stone composition; in the adrenal glands, to characterize adrenal nodules; and in the pancreas, to differentiate between normal and abnormal parenchyma.
Assuntos
Pelve/diagnóstico por imagem , Radiografia Abdominal/métodos , Imagem Radiográfica a Partir de Emissão de Duplo Fóton/métodos , Tomografia Computadorizada por Raios X/métodos , HumanosRESUMO
OBJECTIVE: The purpose of this study was to compare triplanar 2D T2-weighted turbo spin-echo MR images with reformatted images from a 3D T2-weighted turbo spin-echo sequence in analogous planes with respect to acquisition time, image quality, artifacts, and lesion detection. MATERIALS AND METHODS: Forty-four consecutively enrolled women referred for pelvic MRI participated in the study. The protocol included 2D T2-weighted turbo spin-echo sequences in the axial, coronal, and sagittal planes and a single sagittal 3D T2-weighted turbo spin-echo sequence. The acquisition times of the 2D and 3D sequences were calculated. The sagittal 3D data sets were reformatted at 2-mm slice thickness in each plane and compared with the 2D data sets with respect to image quality, artifacts, and lesion detection. RESULTS: The mean acquisition time for the 3D sequence (419 seconds) was significantly shorter than acquisition time for the 2D sequences in three planes (728 seconds) (p < 0.0001). The readers favored the 3D reformats for cervical contrast (p = 0.005); otherwise, there was no significant difference between the 3D reformats and 2D data sets with regard to image quality and lesion detection. The 3D reformats were preferred with respect to respiratory (p < 0.001) and bowel (p < 0.001) motion. CONCLUSION: The 3D approach with multiplanar reconstructions is a promising tool for imaging the female pelvis because of time savings without compromise of image quality, the diagnostic information obtained, and the versatility of reconstructing images in any orientation.
Assuntos
Imageamento Tridimensional , Imageamento por Ressonância Magnética/métodos , Pelve/patologia , Adulto , Artefatos , Diagnóstico Diferencial , Feminino , Humanos , Interpretação de Imagem Assistida por Computador , Pessoa de Meia-Idade , Estudos RetrospectivosAssuntos
Neoplasias do Colo/diagnóstico por imagem , Fluordesoxiglucose F18 , Neurilemoma/diagnóstico por imagem , Tomografia por Emissão de Pósitrons , Tomografia Computadorizada por Raios X , Idoso , Neoplasias do Colo/patologia , Neoplasias do Colo/fisiopatologia , Feminino , Humanos , Neurilemoma/patologia , Neurilemoma/fisiopatologiaRESUMO
OBJECTIVE: The purposes of this study were to retrospectively investigate the effectiveness and safety of CT-guided percutaneous drainage in the treatment of patients with acute appendicitis complicated by perforation and to identify CT findings and procedure-related factors predictive of clinical and procedure outcome. MATERIALS AND METHODS: From March 2005 through December 2008, 41 consecutively registered patients (24 men, 17 women; age range, 18-75 years) underwent CT-guided percutaneous drainage for the management of acute appendicitis complicated by perforation and abscess. Three board-certified radiologists independently reviewed preprocedure CT images. Patients were assigned to one of three risk categories on the basis of the CT findings. Success and failure of percutaneous drainage were defined on a per-patient (i.e., clinical outcome) and per-procedure (i.e., technical outcome) basis. Immediate, periprocedure, and delayed complications were recorded. The association between candidate predictive variables, including demographic characteristics, preprocedure CT findings, and procedure-related factors and clinical or technical outcome was assessed with logistic regression models. RESULTS: Fifty-two CT-guided procedures were performed on 41 patients. Percutaneous drainage had clinical and technical success rates of 90% (37 of 41 patients, 47 of 52 procedures) with no procedure-related complications. In seven patients (19%) clinical success required repeated drainage procedures. A large, poorly defined periappendiceal abscess and an extraluminal appendicolith on preprocedure CT images were independent predictors of clinical failure of percutaneous drainage. CONCLUSION: CT-guided percutaneous drainage is both effective and safe in the treatment of patients with acute appendicitis complicated by perforation and abscess. The clinical and technical success rates are high.
Assuntos
Abscesso Abdominal/cirurgia , Apendicite/cirurgia , Drenagem/métodos , Radiografia Intervencionista , Tomografia Computadorizada por Raios X , Abscesso Abdominal/complicações , Abscesso Abdominal/diagnóstico por imagem , Adolescente , Adulto , Idoso , Apendicite/complicações , Apendicite/diagnóstico por imagem , Feminino , Humanos , Perfuração Intestinal/diagnóstico por imagem , Perfuração Intestinal/etiologia , Perfuração Intestinal/cirurgia , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Resultado do TratamentoRESUMO
OBJECTIVE: The purpose of this study was to corroborate the relation between the estimated absorbed fetal dose derived from directly measured uterine doses early in the first trimester and the volume CT dose index (CTDI(vol)) for 16- and 64-MDCT of the maternal chest, abdomen, and pelvis. MATERIALS AND METHODS: Estimated absorbed fetal dose was measured with a metal oxide semiconductor field effect transistor (MOSFET) dosimeter placed in the expected uterine location in an anthropomorphic phantom of a woman and scanned with 16- and 64-MDCT units of one vendor and a 64-MDCT unit of another vendor. A trauma chest, abdomen, and pelvis protocol and an abdomen and pelvis protocol were used. Absorbed uterine dose was measured directly from the MOSFET detector. The CTDI(vol) for each protocol was recorded from the scanner console. Correlation between mean uterine dose and CTDI(vol) was tested with a goodness of fit model. RESULTS: The absorbed uterine dose ranged from 9.25 to 37.7 mGy. Absorbed fetal dose in the early first trimester correlated with CTDI(vol) in a linear regression equation. For the 16-MDCT scanner, at 130 kVp, the fetal dose was 2.091 x CTDI(vol) - 9.489. For the 64-MDCT scanner from the same vendor, at 120 kVp, the fetal dose was 1.113 x CTDI(vol) + 1.773. For the 64-MDCT scanner from the other vendor, at 120 kVp, the fetal dose was 1.378 x CTDI(vol) - 1.014. The goodness of fit results (R(2)) for the equations were 0.97, 0.98, and 0.99. CONCLUSION: Estimated absorbed fetal dose during the first trimester of pregnancy is linearly associated with CTDI(vol) regardless of beam energy, detector configuration, and scanner manufacturer.
Assuntos
Carga Corporal (Radioterapia) , Feto/diagnóstico por imagem , Tomografia Computadorizada por Raios X , Contagem Corporal Total/métodos , Adulto , Feminino , Humanos , Imagens de Fantasmas , Gravidez , Primeiro Trimestre da Gravidez , Doses de RadiaçãoRESUMO
Acute appendicitis is the most common cause of abdominal pain requiring urgent surgery in the United States. The clinical diagnosis can be difficult in patients with atypical presentations and, over the past several decades, computed tomography (CT) has been increasingly utilized to improve diagnostic accuracy. Helical CT has proven to be an excellent tool in the work-up of acute abdominal pain with a diagnostic accuracy for acute appendicitis of 93-99%. However, occasionally there are equivocal or false positive or negative cases, often due to non-visualization of the appendix. The development of multi-detector row CT and recent advancements in reconstruction software has allowed rapid, high-resolution imaging of the entire abdomen and pelvis resulting in multiplanar reformations (MPR) with a spatial resolution similar to that of the axial plane. This article reviews the utility of CT in suspected acute appendicitis and the potential added diagnostic value of coronal reformations in confirming or excluding the diagnosis.